Optometrist · Aurora, CO
NPI
1174864318
Since 2013
Specialty
Optometrist
Code 152W00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1675 Aurora Ct
Aurora, CO, 80045
Phone (720) 848-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
586 services
Medicare patients, 2024
274
Average age 75
Drug cost, 2024
$2.6M
710 prescriptions
Company payments, 2025
$187K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cecelia C Koetting was code 99214 (office e&m - established), 433 times for 214 patients. In total Cecelia C Koetting billed 586 services in 11 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 433 | 214 | $71.18 | $31K |
| 99213 Office E&M - Established | Facility | 60 | 50 | $46.74 | $2,805 |
| 99204 Office E&M - New | Facility | 58 | 58 | $95.93 | $5,564 |
| 92134 Computerized Ophthalmic Imaging | Facility | 16 | 14 | $18.25 | $292 |
By year: 2022 $50K for 618 services; 2023 $16K for 285 services; 2024 $41K for 586 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cecelia C Koetting prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 94 prescriptions and refills. In total Cecelia C Koetting wrote 710 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 94 | 214 | 53 | $142K |
| Restasis Cyclosporine | 88 | 186 | 47 | $109K |
| Loteprednol Etabonate Generic | 66 | 71 | 47 | $8,949 |
| Restasis Multidose Cyclosporine | 60 | 84 | 17 | $55K |
| Xdemvy Lotilaner | 52 | 83 | 50 | $96K |
| Valacyclovir Valacyclovir Hcl | 44 | 70 | 12 | $4,295 |
| Oxervate Cenegermin-Bkbj | 41 | 41 | 11 | $2.0M |
| Cyclosporine Generic | 35 | 94 | 23 | $31K |
| Fluorometholone Generic | 33 | 46 | 23 | $2,742 |
| Miebo Perfluorohexyloctane/Pf | 30 | 47 | 11 | $42K |
| Tyrvaya Varenicline Tartrate | 20 | 26 | Under 11 | $15K |
| Azithromycin Generic | 14 | 14 | 13 | $64.87 |
| Prednisolone Acetate Generic | 12 | 23 | Under 11 | $509 |
| Cequa Cyclosporine | 11 | 25 | Under 11 | $14K |
Brand drugs: 529 claims; generic drugs: 181 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cecelia C Koetting $187K ($187K in general payments such as food, travel and fees) from 15 companies. The largest payer was Bausch & Lomb Americas Inc. with $63K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 61 | $63K |
| Dompe US, Inc. | 109 | $47K |
| Tarsus Pharmaceuticals, Inc. TARS | 53 | $34K |
| Alcon Vision LLC ALC | 31 | $24K |
| Harrow Eye, LLC | 13 | $4,683 |
| Alcon Research LLC ALC | 2 | $3,750 |
| Abbvie Inc. ABBV | 10 | $3,376 |
| Glaukos Corporation GKOS | 3 | $2,003 |
| Nordic Pharma, Inc. | 1 | $1,400 |
| Pfizer Inc. PFE | 2 | $1,260 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.